InvestorsHub Logo
Followers 37
Posts 7217
Boards Moderated 1
Alias Born 09/06/2014

Re: Gold Seeker post# 27395

Wednesday, 01/21/2015 9:03:58 PM

Wednesday, January 21, 2015 9:03:58 PM

Post# of 30046
Agreed, Charter didn't have the IP before May 2014. Radient wasn't licensing the IP to anyone back when Charter was "inventing" his test and "conducting" his clinical trials prior to 2012.

Charter claims to have conducted clinical trials with 6,600 participants without publishing any scientific data. Something is very suspicious there. I don't see how any scientist could conduct trials with that many participants and claim the trials a success without publishing the results.

Same for GCDx. Why don't they publish their data? They claim their trials (or "validation studies" or whatever they are calling it) were successful. How can they expect the medical community to just take their word for it?


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.